VRCA | Verrica Pharmaceuticals Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.2100 - 1.2900
52 Week Range	0.7040 - 11.41
Beta	1.75
Implied Volatility	237.46%
IV Rank	50.12%
Day's Volume	299,423
Average Volume	883,000
Shares Outstanding	90,564,800
Market Cap	109,583,408
Sector	Healthcare
Industry	Biotechnology
IPO Date	2018-06-15

Valuation
Profitability
Growth
Health
P/E Ratio	-0.66
Forward P/E Ratio	N/A
EPS	-1.84
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	100
Country	USA
Website	VRCA

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

VRCA's peers: BLRX, ITRM, IVA, MESO, PHAR, TCRT, THTX, LIAN, EWTX, VIGL, CNTB, ABOS, ETON, NUVB, ELDN, VRNA, GRTX, ARQT, PLX, KDNY, DICE, PLRX, CRNX, ASND, FENC, LRMR, FIXX

*Chart delayed

Analyzing fundamentals for VRCA we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see VRCA Fundamentals page.

Watching at VRCA technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on VRCA Technicals page.